Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

Anne Sophie Kubasch, Freya Schulze, Aristoteles Giagounidis, Katharina S. Götze, Jan Krönke, Katja Sockel, Jan Moritz Middeke, Fatiha Chermat, Silke Gloaguen, Martin Puttrich, Carmen Weigt, Doreen William, Pierre Fenaux, Richard F. Schlenk, Christian Thiede, Sebastian Stasik, Anna Mies, Lionel Adès, Uta Oelschlägel, Uwe Platzbecker

Research output: Contribution to journalArticlepeer-review

38 Scopus citations
Original languageEnglish
Pages (from-to)1182-1186
Number of pages5
JournalLeukemia
Volume34
Issue number4
DOIs
StatePublished - Apr 2020
Externally publishedYes

Cite this